Smith+Nephew announces strong performance results for joint replacement technology

Global medical technology company Smith+Nephew’s OXINIUM technology has shown strong performance measures in hip and knee arthroplasties.

Advertisement

OXINIUM is made with zirconium alloy that transforms into ceramicised metal through oxidation for enhanced performance, according to an Aug. 30 news release.

Using four national and regional joint registries with more than 2 million procedures over the past 20 years, the company found that its joint replacement technology showed the lowest risk of revision at 10 years for hip arthroplasties and high survivorship in total knee arthroplasty.

Smooth+Nephew also reported that its OXINIUM technology is associated with increased savings and lower readmission rates.

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.